Literature DB >> 28404863

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Michael E Ward1,2,3, Robert Chen1,3, Hsin-Yi Huang4,5, Connor Ludwig1,3, Maria Telpoukhovskaia1, Ali Taubes1, Helene Boudin4,6, Sakura S Minami1, Meredith Reichert1, Philipp Albrecht7, Jeffrey M Gelfand3, Andres Cruz-Herranz3, Christian Cordano3, Marcel V Alavi8, Shannon Leslie1, William W Seeley3, Bruce L Miller3, Eileen Bigio9, Marek-Marsel Mesulam9, Matthew S Bogyo10, Ian R Mackenzie11, John F Staropoli12, Susan L Cotman12, Eric J Huang4,13, Li Gan14,3, Ari J Green15,8.   

Abstract

Heterozygous mutations in the GRN gene lead to progranulin (PGRN) haploinsufficiency and cause frontotemporal dementia (FTD), a neurodegenerative syndrome of older adults. Homozygous GRN mutations, on the other hand, lead to complete PGRN loss and cause neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease usually seen in children. Given that the predominant clinical and pathological features of FTD and NCL are distinct, it is controversial whether the disease mechanisms associated with complete and partial PGRN loss are similar or distinct. We show that PGRN haploinsufficiency leads to NCL-like features in humans, some occurring before dementia onset. Noninvasive retinal imaging revealed preclinical retinal lipofuscinosis in heterozygous GRN mutation carriers. Increased lipofuscinosis and intracellular NCL-like storage material also occurred in postmortem cortex of heterozygous GRN mutation carriers. Lymphoblasts from heterozygous GRN mutation carriers accumulated prominent NCL-like storage material, which could be rescued by normalizing PGRN expression. Fibroblasts from heterozygous GRN mutation carriers showed impaired lysosomal protease activity. Our findings indicate that progranulin haploinsufficiency caused accumulation of NCL-like storage material and early retinal abnormalities in humans and implicate lysosomal dysfunction as a central disease process in GRN-associated FTD and GRN-associated NCL.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28404863      PMCID: PMC5526610          DOI: 10.1126/scitranslmed.aah5642

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  29 in total

Review 1.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

2.  Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.

Authors:  Fenghua Hu; Thihan Padukkavidana; Christian B Vægter; Owen A Brady; Yanqiu Zheng; Ian R Mackenzie; Howard H Feldman; Anders Nykjaer; Stephen M Strittmatter
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

3.  Seizures and epileptiform activity in the early stages of Alzheimer disease.

Authors:  Keith A Vossel; Alexander J Beagle; Gil D Rabinovici; Huidy Shu; Suzee E Lee; Georges Naasan; Manu Hegde; Susannah B Cornes; Maya L Henry; Alexandra B Nelson; William W Seeley; Michael D Geschwind; Maria L Gorno-Tempini; Tina Shih; Heidi E Kirsch; Paul A Garcia; Bruce L Miller; Lennart Mucke
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

4.  Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling.

Authors:  Jindong Xu; Maria Xilouri; Julien Bruban; Junichi Shioi; Zhiping Shao; Ioannis Papazoglou; Kostas Vekrellis; Nikolaos K Robakis
Journal:  Neurobiol Aging       Date:  2011-08-04       Impact factor: 4.673

5.  TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.

Authors:  Alexandra M Nicholson; Nicole A Finch; Aleksandra Wojtas; Matt C Baker; Ralph B Perkerson; Monica Castanedes-Casey; Linda Rousseau; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Ging-Yuek R Hsiung; Ian R Mackenzie; Elizabeth Finger; Bradley F Boeve; Nilüfer Ertekin-Taner; Neill R Graff-Radford; Dennis W Dickson; Rosa Rademakers
Journal:  J Neurochem       Date:  2013-07-01       Impact factor: 5.372

Review 6.  Potential mechanisms of progranulin-deficient FTLD.

Authors:  Michael Emmerson Ward; Bruce L Miller
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

Review 7.  Neuronal ceroid lipofuscinoses.

Authors:  Anu Jalanko; Thomas Braulke
Journal:  Biochim Biophys Acta       Date:  2008-11-24

8.  The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.

Authors:  Benjamin M Schwenk; Christina M Lang; Sebastian Hogl; Sabina Tahirovic; Denise Orozco; Kristin Rentzsch; Stefan F Lichtenthaler; Casper C Hoogenraad; Anja Capell; Christian Haass; Dieter Edbauer
Journal:  EMBO J       Date:  2013-12-19       Impact factor: 11.598

9.  Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.

Authors:  Lauren Herl Martens; Jiasheng Zhang; Sami J Barmada; Ping Zhou; Sherry Kamiya; Binggui Sun; Sang-Won Min; Li Gan; Steven Finkbeiner; Eric J Huang; Robert V Farese
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

10.  Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.

Authors:  Philip Van Damme; Annelies Van Hoecke; Diether Lambrechts; Peter Vanacker; Elke Bogaert; John van Swieten; Peter Carmeliet; Ludo Van Den Bosch; Wim Robberecht
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  75 in total

1.  Progranulin in the hematopoietic compartment protects mice from atherosclerosis.

Authors:  Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese
Journal:  Atherosclerosis       Date:  2018-08-30       Impact factor: 5.162

2.  Regulation of cathepsin D activity by the FTLD protein progranulin.

Authors:  Xiaolai Zhou; Daniel H Paushter; Tuancheng Feng; Cara M Pardon; Christina S Mendoza; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2017-05-10       Impact factor: 17.088

3.  Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.

Authors:  Lisa P Elia; Amanda R Mason; Amela Alijagic; Steven Finkbeiner
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

4.  Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.

Authors:  Victoria J Butler; Wilian A Cortopassi; Andrea R Argouarch; Sam L Ivry; Charles S Craik; Matthew P Jacobson; Aimee W Kao
Journal:  J Mol Biol       Date:  2019-01-25       Impact factor: 5.469

5.  A zebrafish model of granulin deficiency reveals essential roles in myeloid cell differentiation.

Authors:  Clyde A Campbell; Oksana Fursova; Xiaoyi Cheng; Elizabeth Snella; Abbigail McCune; Liangdao Li; Barbara Solchenberger; Bettina Schmid; Debashis Sahoo; Mark Morton; David Traver; Raquel Espín-Palazón
Journal:  Blood Adv       Date:  2021-02-09

6.  Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography.

Authors:  Fang Ko; Zaynah A Muthy; John Gallacher; Cathie Sudlow; Geraint Rees; Qi Yang; Pearse A Keane; Axel Petzold; Peng T Khaw; Charles Reisman; Nicholas G Strouthidis; Paul J Foster; Praveen J Patel
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

7.  Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

Authors:  Zoe A Klein; Hideyuki Takahashi; Mengxiao Ma; Massimiliano Stagi; Melissa Zhou; TuKiet T Lam; Stephen M Strittmatter
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

Review 8.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 9.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

10.  Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.

Authors:  Andrew E Arrant; Vincent C Onyilo; Daniel E Unger; Erik D Roberson
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.